Ebola Virus Breakouts-What its The Business Benefits

The Ebola virus outbreak in Western Africa dominated much of the stories in 2014. The highly communicable pathogen spreads quickly and kills more than half of those people who become infected, resulting in major panics across multiple continents. While the vast majority of the dead are in Africa, health employees did bring the virus home to other nations and continents.

For all of the doom and gloom and focus on doomsday scenarios on what the virus could do, there are actually dome economic benefits of Ebola virus outbreaks. The industrial benefits largely breakdown between nonprofit or state groups and for-profit biotechnology firms.

Government or aid setups like the Red Cross or the CDC have a tendency to see increases in funding in events like these. The economic benefits to them are direct and help out those on the ground suffering or helping and containing an onset.

This containment keeps business interruption when funding is acceptable to turn the tide of an outbreak.

The longer-term economic benefits of ebola virus">benefits of Ebola virus onsets are biotech corporations working on vaccines or medicines that might improve survival rates of those infected by Ebola. One such firm is Tekmira, which has been given blessings by the FDA to broaden testing on in its experimental Ebola drug for larger scale controlled trials.

Sarepta Therapeutics, Nanoviricides and BioCryst Pharmaceuticals are other biotech outfits that would see increased business in the future if their own Ebola drugs and medications turn out to be of price.

While the 2014 Ebola break out is first to have caught world attention as much as it did, it was barely the first breakout. Others have occurred, and more will happen in times to come. Any business that has an Ebola drug or vaccine on the market that proves effective can be sure to see a rise in business in times to come.